Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial
Thananda Trakarnvanich, Bancha Satirapoj, Swangjit Suraamornkul, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 16

Showing 16 citing articles:

Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation
Qichao Hu, Yuan Chen, Xinyu Deng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114252-114252
Open Access | Times Cited: 103
Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment
Ruili Yin, Yongsong Xu, Xin Wang, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3055-3055
Open Access | Times Cited: 51
Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
Yu Wang, Mingyue Jin, Chak Kwong Cheng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 41
Vascular calcification: Molecular mechanisms and therapeutic interventions
Wei Pan, Wei Jie, Hui Huang
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 39
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 32
Vascular calcification and cellular signaling pathways as potential therapeutic targets
Jeong‐Hun Kang, Takahito Kawano, Masaharu Murata, et al.
Life Sciences (2023) Vol. 336, pp. 122309-122309
Closed Access | Times Cited: 15
Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy
Feng Liu, Haipeng Cai
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Meta-Analysis on the Association Between DPP-4 Inhibitors and Bone Mineral Density and Osteoporosis
Lili Huang, Wei Zhong, Xinghuan Liang, et al.
Journal of Clinical Densitometry (2023) Vol. 27, Iss. 1, pp. 101455-101455
Open Access | Times Cited: 8
Construction of a Nomogram-Based Prediction Model for the Risk of Diabetic Kidney Disease in T2DM
Xian Wang, Xiaming Liu, Jun Zhao, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 215-225
Open Access | Times Cited: 2
Effect of DPP-4i inhibitors on renal function in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Yong Gong, Xueyan Bai, Donglei Zhang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Alogliptin exhibits multifaceted effects in thioacetamide-insulted rats: A novel approach to combating hepatic inflammation and fibrogenesis
Osama A. Mohammed
Pathology - Research and Practice (2023) Vol. 250, pp. 154833-154833
Closed Access | Times Cited: 4
Licochalcone A Derivatives as Selective Dipeptidyl Peptidase 4 Inhibitors with Anti-Inflammatory Effects
Ci-Qin Li, Jinhui Shi, Jie Mu, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 7, pp. 1824-1831
Closed Access | Times Cited: 3
Effect of dipeptidyl peptidase‐4 inhibitor on the progression of coronary artery disease evaluated by computed tomography in patients receiving insulin therapy for type 2 diabetes mellitus
Young Choi, Seung‐Hyun Ko, Kiyuk Chang, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 11, pp. 944-954
Open Access | Times Cited: 2
Safety and Efficiency of Dipeptidyl Peptidase IV Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
Adili Tuersun, Munire Mohetaer, Guanxin Hou, et al.
Current Therapeutic Research (2024) Vol. 101, pp. 100763-100763
Open Access
Study of molecular mechanisms underlying the medicinal plant Tripterygium wilfordii-derived compound celastrol in treating diabetic nephropathy based on network pharmacology and molecular docking
Fengmei Qian, Peiyao Ren, Li Zhao, et al.
Biocell (2023) Vol. 47, Iss. 8, pp. 1853-1867
Open Access | Times Cited: 1
The Effects of Non-Insulin Anti-Diabetic Medications on the Diabetic Microvascular Complications: A Systemic Review and Meta-Analysis of Randomized Clinical Trials
Dongxiang Xu, Yue Yuan, Song Wen, et al.
(2023)
Closed Access
Page 1

Scroll to top